| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |